Browse by topics
THE BIG READ
4 min read • 2 hours ago
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are reaching a tipping point. We investigate the shadow economy of premium medicine.
-
Expansion
Why the 'Patent Cliff' is Actually a Catalyst for True Innovation
Industry veteran Dr. Robert Chen argues that expiring protections are the best thing to happen to the R&D pipeline in decades.
-
Environment
The Automation Crisis in Bio-Manufacturing
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
-
Strategy
Visualizing the 2024 VC Capital Flow into CNS Disorders
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
[Sponsored Content Placeholder]
THE BIG READ
4 min read • 2 hours ago
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are reaching a tipping point. We investigate the shadow economy of premium medicine.
-
Expansion
Why the 'Patent Cliff' is Actually a Catalyst for True Innovation
Industry veteran Dr. Robert Chen argues that expiring protections are the best thing to happen to the R&D pipeline in decades.
-
Environment
The Automation Crisis in Bio-Manufacturing
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
-
Strategy
Visualizing the 2024 VC Capital Flow into CNS Disorders
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
[Sponsored Content Placeholder]
THE BIG READ
4 min read • 2 hours ago
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are reaching a tipping point. We investigate the shadow economy of premium medicine.
-
Expansion
Why the 'Patent Cliff' is Actually a Catalyst for True Innovation
Industry veteran Dr. Robert Chen argues that expiring protections are the best thing to happen to the R&D pipeline in decades.
-
Environment
The Automation Crisis in Bio-Manufacturing
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
-
Strategy
Visualizing the 2024 VC Capital Flow into CNS Disorders
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
[Sponsored Content Placeholder]
THE BIG READ
4 min read • 2 hours ago
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are reaching a tipping point. We investigate the shadow economy of premium medicine.
-
Expansion
Why the 'Patent Cliff' is Actually a Catalyst for True Innovation
Industry veteran Dr. Robert Chen argues that expiring protections are the best thing to happen to the R&D pipeline in decades.
-
Environment
The Automation Crisis in Bio-Manufacturing
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
-
Strategy
Visualizing the 2024 VC Capital Flow into CNS Disorders
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
[Sponsored Content Placeholder]
THE BIG READ
4 min read • 2 hours ago
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are reaching a tipping point. We investigate the shadow economy of premium medicine.
-
Expansion
Why the 'Patent Cliff' is Actually a Catalyst for True Innovation
Industry veteran Dr. Robert Chen argues that expiring protections are the best thing to happen to the R&D pipeline in decades.
-
Environment
The Automation Crisis in Bio-Manufacturing
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
-
Strategy
Visualizing the 2024 VC Capital Flow into CNS Disorders
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
[Sponsored Content Placeholder]
THE BIG READ
4 min read • 2 hours ago
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are reaching a tipping point. We investigate the shadow economy of premium medicine.
-
Expansion
Why the 'Patent Cliff' is Actually a Catalyst for True Innovation
Industry veteran Dr. Robert Chen argues that expiring protections are the best thing to happen to the R&D pipeline in decades.
-
Environment
The Automation Crisis in Bio-Manufacturing
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
-
Strategy
Visualizing the 2024 VC Capital Flow into CNS Disorders
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
[Sponsored Content Placeholder]
THE BIG READ
4 min read • 2 hours ago
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are reaching a tipping point. We investigate the shadow economy of premium medicine.
-
Expansion
Why the 'Patent Cliff' is Actually a Catalyst for True Innovation
Industry veteran Dr. Robert Chen argues that expiring protections are the best thing to happen to the R&D pipeline in decades.
-
Environment
The Automation Crisis in Bio-Manufacturing
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
-
Strategy
Visualizing the 2024 VC Capital Flow into CNS Disorders
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
[Sponsored Content Placeholder]
THE BIG READ
4 min read • 2 hours ago
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are reaching a tipping point. We investigate the shadow economy of premium medicine.
-
Expansion
Why the 'Patent Cliff' is Actually a Catalyst for True Innovation
Industry veteran Dr. Robert Chen argues that expiring protections are the best thing to happen to the R&D pipeline in decades.
-
Environment
The Automation Crisis in Bio-Manufacturing
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
-
Strategy
Visualizing the 2024 VC Capital Flow into CNS Disorders
Will the rise of the autonomous lab displace human researchers or simply free them for higher-level synthesis?
[Sponsored Content Placeholder]
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.
[Sponsored Content Placeholder]
The Next Frontier of Bioprocessing: How AI is Optimizing Viral Vector Production
Regulatory Dealmaking Supply chain
Sun Pharma expanding Princeton HQ with $5.2M in tax credits 4 min read • 2 hours ago
Regulatory Dealmaking Supply chain
FTC Challenges 'Product Hopping' in Landmark Biopharma Lawsuit 4 min read • 2 hours ago
Trending Stories
-
Supply chain
BMS Receives FDA Priority Review for New Melanoma Combination -
Regulatory Dealmaking
Sanofi Invests $1.2B in mRNA Research Center Expansion -
Future Biopharma
European Medicines Agency Issues Guidelines on Decentralized Trials -
Regulatory Dealmaking Supply chain
Novo Nordisk Reports Record Growth Driven by Ozempic Demand -
Regulatory Dealmaking Supply chain
Novo Nordisk Reports Record Growth Driven by Ozempic Demand -
Future Biopharma
Sanofi Invests $1.2B in mRNA Research Center Expansion
Multimedia Insights
Webinar: Novo Nordisk Reveals Headline Phase III Trial Results Evaluating Combination Treatment
08:12 mins • 2 hours ago
Inside the Lab: How Bio-Robotics are Revolutionizing
08:12 mins • 2 hours ago
Pharma Market Recap: Global Mergers to Watch
08:12 mins • 2 hours ago
The Future of CRISPR: Roundtable with Clinical Leaders
08:12 mins • 2 hours ago
The Future of CRISPR: Roundtable with Clinical Leaders
08:12 mins • 2 hours ago
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.
R&D
- Virginia governor vetoes legislation to create an advisory panel to lower the cost of prescription drugs 4 min read • 2 hours ago
- STAT Plus:This spine surgery usually costs $1,400. Under No Surprises Act arbitration? $34,000 5 min read • just now
- Canadian medical societies lack sufficient conflict-of-interest policies, study finds 3 min read • 1 hour ago
Dealmaking
- Test your knowledge with our now weekday mini crossword 6 min read • 30 minutes ago
- STAT Plus:Eli Lilly tops prominent rankings on pharma R&D performance 4 min read • 45 minutes ago
- Britain embraces a Massachusetts experiment on tobacco regulation — just as the state might roll it back 7 min read • 15 minutes ago
Future Biopharma
- 1 in 8 women drink during pregnancy. Experts dread the consequences 2 min read • 1 hour ago
- At a time of tumult at FDA, a former commissioner is hopeful it’s on a better path 8 min read • 10 minutes ago
- Marc Tessier-Lavigne addresses new book’s allegations about his conduct in Stanford misconduct case 3 min read • 20 minutes ago
Regulatory
- Maryland state affordability board places a price cap on Ozempic 5 min read • 5 minutes ago
- White House taps Amazon, GoodRx, and Mark Cuban to bolster TrumpRx 4 min read • 2 hours ago
- U.S. bans entry from Ebola-affected countries as American patient is identified 6 min read • 1 hour ago
[Sponsored Content Placeholder]
Upcoming Events
The summit has built a reputation providing on great content. The agenda is packed with carefully selected talks on diverse topics including challenges faced by the field. Featuring four parallel streams, the event offers tailored agendas, allowing participants to delve deeply into topics relevant to their specific challenges.
CDMO Live 2026 is the global meeting place for leaders in outsourced biopharma development and manufacturing.
The Bio-IT World Conference & Expo is the premier global event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine.
The Cleanroom Technology Conference showcases the latest innovations and trends in the cleanroom industry. The program highlights new practices, future projections, and solutions that are shaping cleanroom technology worldwide